IGFBP3 and breast cancer: Li et al’s meta-analysis showed significant association was found in additive genetic model between IGFBP3 A-202C SNP and breast cancer and prostate cancer [14], Chen et al’s meta-analysis suggest IGFBP3 202CC genotype was associated with an increased risk of prostate cancer with borderline significance [15].